Good afternoon :)
Place Order
Add to Watchlist

Tejnaksh Healthcare Ltd

TEJNAKSH

Tejnaksh Healthcare Ltd

TEJNAKSH
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹52 cr, stock is ranked 3,475
High RiskStock is 3.29x as volatile as Nifty
25.712.23% (+0.56)
25.712.23% (+0.56)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹52 cr, stock is ranked 3,475
High RiskStock is 3.29x as volatile as Nifty

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹52 cr, stock is ranked 3,475
High RiskStock is 3.29x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
23.772.15
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
52.296.680.47%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Tejnaksh Healthcare Limited is engaged in hospital activities. The Company offers healthcare services at 13 urology clinics, four urology hospitals and two dental super specialty clinics. The Company is operating one hospital at Dhule in Maharashtra.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -10.13%, vs industry avg of 10.02%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.06% to 0.02%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -10.03%, vs industry avg of 42.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue4.787.4714.5321.3117.4612.1012.8312.0412.4912.57
Raw Materialssubtract0.710.961.611.311.100.961.441.341.408.10
Power & Fuel Costsubtract0.140.230.200.360.330.250.220.240.26
Employee Costsubtract0.200.762.052.932.551.391.321.371.37
Selling & Administrative Expensessubtract1.092.043.067.285.663.673.173.483.95
Operating & Other expensessubtract0.310.101.883.703.441.981.771.591.56
Depreciation/Amortizationsubtract0.210.350.470.590.650.680.670.870.910.92
Interest & Other Itemssubtract0.000.200.980.780.760.500.480.620.660.61
Taxes & Other Itemssubtract0.801.021.411.340.880.621.040.830.600.75
EPS0.650.891.411.491.031.011.340.840.881.08
DPS0.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2021

Annual report

PDF

Investor Presentation

Sep 17PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Tejnaksh Healthcare Ltd29.252.15
Apollo Hospitals Enterprise Ltd111.7413.720.23%
Max Healthcare Institute Ltd86.3810.870.16%
Fortis Healthcare Ltd75.675.300.17%

Price Comparison

Compare TEJNAKSH with any stock or ETF
Compare TEJNAKSH with any stock or ETF
TEJNAKSH
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.30%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding73.83%0.00%0.00%0.00%26.17%

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Shareholding History

MarJunSepDec '23MarJun0.58%0.58%0.58%0.58%0.28%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

TEJNAKSH has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Tejnaksh Healthcare schedules AGM

Tejnaksh Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Tejnaksh Healthcare to hold AGM

Tejnaksh Healthcare announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Tejnaksh Healthcare consolidated net profit rises 275.00% in the June 2024 quarter

Net profit of Tejnaksh Healthcare rose 275.00% to Rs 0.60 crore in the quarter ended June 2024 as against Rs 0.16 crore during the previous quarter ended June 2023. Sales rose 2.97% to Rs 3.12 crore in the quarter ended June 2024 as against Rs 3.03 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.123.03 3 OPM %34.6217.16 - PBDT1.030.44 134 PBT0.800.21 281 NP0.600.16 275 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Tejnaksh Healthcare to conduct board meeting

Tejnaksh Healthcare will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live